Market News

NASDAQ:VYGR News

2 stories
tradingview

VYGR Q2'26 Earnings: revenue estimate is 4.56M USD

VYGR (Voyager Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 4.56 million USD with EPS (earnings per share) anticipated at (0.50) USD. Learn more details a…

TradingView en
StocksUS
globenewswire

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

LEXINGTON, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. NASDAQ:VYGR, a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced a Developing Topics (late-breaking) poster presentation at the upcoming Alzheimer's Association Intern…

GlobeNewswire en
StocksUS